A Phase 1 Clinical Trial to Evaluate the Plasma Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Subjects

Trial Profile

A Phase 1 Clinical Trial to Evaluate the Plasma Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Feb 2018

At a glance

  • Drugs Zoliflodacin (Primary)
  • Indications Gonorrhoea
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Feb 2018 Planned initiation date changed from 17 Jan 2018 to 14 Feb 2018.
    • 22 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top